ESR2 and hepatocellular carcinoma: The protecting role reported for estradiol (E2) in chronic liver diseases, including HCC, has also been attributed to the anti-proliferative and anti-inflammatory activities brought about by E2 through binding to and activation of estrogen receptor beta (ERβ) [37].